Business Wire

FourKites Expands Executive Leadership Team with Bo Tao, Chief Technology Officer, and Manik Mair, SVP Corporate Growth

27.7.2023 12:12:00 EEST | Business Wire | Press release

Share

Leading supply chain visibility provider FourKites today announces it has expanded its leadership team with two seasoned executives: Chief Technology Officer Dr. Bo Tao and Senior Vice President of Corporate Growth Manik Mair. These recent executive additions come at a time of rapid customer expansion and global company growth, as FourKites doubles down on its mission to deliver supply chain visibility everywhere, and its unwavering commitment to customer success.

Dr. Bo Tao, CTO, will drive product innovation across FourKites’ technology portfolio with a particular focus on artificial intelligence and machine learning, as well as customer-led product growth. Tao is an experienced engineering leader and an industry veteran, having worked in the logistics and software industry for over 20 years. His expertise spans full-stack development, machine learning and data engineering, with experience at NEXT Trucking, Google, Symantec, Dell Technologies and Cheetah Mobile. Tao holds 10 patents, as well as a PhD from Princeton University.

“Through the integration work my Next Trucking team did with FourKites, I experienced firsthand the value that FourKites’ solutions brought not only to that business but also to the entire supply chain ecosystem,” says Tao. “Now, as FourKites’ CTO, my goal is to create a holistic technology landscape that delivers the best possible results, while simultaneously focusing on engineering excellence, execution and building for scale to accommodate our rapidly growing customer base.”

Manik Mair, SVP of Corporate Growth, is responsible for defining and implementing FourKites’ corporate growth agenda across all domains, functions and regions. An experienced software executive and business strategist, Mair was most recently the Global Vice President, Head of GTM Strategy, at Ceridian (NYSE:CDAY), where he helped define and implement the go-to-market strategy across all regions, offerings and channels. Prior to that, Mair was part of EY’s strategy consulting practice, where he focused on corporate, portfolio and business unit strategy, digital transformation and go-to-market strategy.

“FourKites’ visionary approach and ceaseless innovation continually push the boundaries of what’s possible, delivering transformational value to our customers,” says Mair. “I’m thrilled to join the team, not only to build robust, cross-functional growth capabilities, but also to support FourKites’ increasing focus on helping our customers grow effectively and efficiently.”

“Customer-led innovation and product growth have been ingrained in our company’s DNA since our inception, and remain so as we continue to grow,” says FourKites founder and CEO Mathew Elenjickal. “Bo’s and Manik’s commitment to customer success and innovation exemplify what we value most at FourKites, and we are thrilled to have them join our team.”

FourKites’ leadership expansion highlights the company’s strong, sustained growth across the globe. Earlier this month, the company announced the expansion of its teams dedicated to driving innovation for key verticals, and helping customers maximise the value they derive from the platform. Over the last 12 months, the company has experienced nearly 40% YoY increase in customers, as well as nearly 40% growth in the number of shipments tracked in the FourKites platform — across 95% of the world’s ports and more than 200 countries and territories. FourKites’ carrier network now totals 530,000+, with nearly 1 million downloads of FourKites’ CarrierLink mobile app.

About FourKites

Leading global supply chain visibility platform FourKites® extends visibility beyond transportation into yards, warehouses, stores and beyond. Tracking more than 3 million shipments daily across road, rail, ocean, air, parcel and last mile, and reaching over 200 countries and territories, FourKites combines real-time data and powerful machine learning to help companies digitise their end-to-end supply chains. More than 1,200 of the world’s most recognised brands — including 9 of the top-10 CPG and 18 of the top-20 food and beverage companies — trust FourKites to transform their business and create more agile, efficient and sustainable supply chains. To learn more, visit https://www.fourkites.com/.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Scott Johnston
European PR Director, FourKites
+31 62 147 8442
scott.johnston@fourkites.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 14:00:00 EEST | Press release

Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early, subtle symptoms. Individuals in this stage, classified as CHR-P, represent a critical pr

SINOVAC Announces Extension of Deadline to Submit Payment Instructions for Previously Declared Special Cash Dividend21.5.2026 13:30:00 EEST | Press release

Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has extended the deadline for shareholders and nominee brokers to submit payment instructions relating to the Company’s previously declared special cash dividend. The Company previously announced a special cash dividend of US$55.00 per common share, payable to valid holders of the Company’s common shares as of the close of business on May 23, 2025 ET. The Company previously informed shareholders that completed instruction materials were to be submitted prior to December 31, 2025 in order to facilitate receipt of the dividend. The Company has now extended that submission deadline to June 30, 2026. Shareholders and nominee brokers that have not yet submitted their instruction materials are reminded to do so on or before June 30, 2026 in order to facilitate payment of the dividend. If you have any questions regarding the process you need to un

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye